CanniMed Q1 Sales grow 8% from Q4


cannimed-therapeutics

CanniMed Therapeutics Inc. Reports Financial Results for Q1 2017

March 16, 2017

SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (“CanniMed” or the “Company”) (TSX: CMED) (OTC: CMMDF) today released its financial results for its first quarter ended January 31, 2017.

Our medical cannabis sales increased dramatically during the quarter, with

... read more at: https://www.newcannabisventures.com/cannimed-q1-sales-grow-8-from-q4/

by